# Risk Factors and Machine Learning Model for Beta-Lactam Drugs Related Acute Kidney Injury

> **NCT05533606** · — · COMPLETED · sponsor: **Qianfoshan Hospital** · enrollment: 19000 (actual)

## Conditions studied

- Acute Kidney Injury
- Beta-Lactam Antibiotic Toxicity (Diagnosis)

## Interventions

- **DRUG:** Beta-Lactam Drugs

## Key facts

- **NCT ID:** NCT05533606
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 19000 (ACTUAL)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05533606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05533606, "Risk Factors and Machine Learning Model for Beta-Lactam Drugs Related Acute Kidney Injury". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05533606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*